Preventing organ transplant rejection

Researchers at the University of Virginia have developed a new approach to prevent organ rejection using nanoparticles to modify immune cells. The technique targets a specific protein in monocytes, training the immune system to tolerate transplanted organs without compromising overall immune function. This breakthrough could eliminate the need for lifelong immunosuppressive drugs in transplant patients and has potential applications for treating autoimmune disorders.